A higher proportion of PU.1+ Th9 cells, IRF4+ Th9 cells, and CD4+IL-9+ Th9 cells was observed in the PBMCs of patients with RA than in those of healthy controls (43–46) (Table 1). This evidence concerns the gene CD4 and rheumatoid arthritis.